Financial Outlook
For the fourth quarter 2022, thredUP expects:
Revenue in the range of $62 million to $64 million
Gross margin in the range of 62.0% to 64.0%
Adjusted
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Over the past 3 months, 6 analysts have published their opinion on ThredUp (NASDAQ:TDUP) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.